dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Brasó-Maristany, Fara |
dc.contributor.author | Griguolo, Gaia |
dc.contributor.author | Pascual, Tomás |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Llombart-Cussac, Antonio |
dc.contributor.author | Antunes de Melo Oliveira, Ana Mafalda |
dc.contributor.author | Paré, Laia |
dc.date.accessioned | 2021-09-02T09:10:32Z |
dc.date.available | 2021-09-02T09:10:32Z |
dc.date.issued | 2020-01-20 |
dc.identifier.citation | Brasó-Maristany F, Griguolo G, Pascual T, Paré L, Nuciforo P, Llombart-Cussac A, et al. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. Nat Commun. 2020 Jan 20;11:385. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/6256 |
dc.description | Càncer de mama; Expressió gènica; Oncologia |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Nature Communications;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-019-14111-3 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1038/s41467-019-14111-3 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Brasó-Maristany F] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. [Griguolo G] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani, 2, 35124 Padova, Italy. Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Via Gattamelata, 64, 35128 Padova, Italy. [Pascual T] Department of Medical Oncology, Hospital Clínic de Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Carrer del Rosselló, 149-153, 08036 Barcelona, Spain. SOLTI Breast Cancer Research Group, Carrer de Balmes, 115, 08008 Barcelona, Spain. [Paré L] SOLTI Breast Cancer Research Group, Carrer de Balmes, 115, 08008 Barcelona, Spain. [Nuciforo P, Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Llombart-Cussac A] Hospital Universitario Arnau de Vilanova, Carrer de Sant Clement, 12, 46015 Valencia, Spain |
dc.identifier.pmid | 31959756 |
dc.identifier.wos | 000512537400006 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |
Fitxers en aquest element
Aquest element apareix en la col·lecció o col·leccions següent(s)
-
HVH - Articles científics [2896]
-
VHIO - Articles científics [846]